Agennix planning rights issue

Agennix AG (Xetra:AGX) plans to raise up to EUR 78.4 million ($100.5 million) through the sale of up to 20.6 million shares at EUR 3.81 in a rights offering. The price is a 10% discount to Agennix's close of EUR 4.23 on Tuesday, before the deal was announced. Shareholders are eligible to purchase one share for every share held. Shares not subscribed in the rights offering will be offered to institutional investors outside Germany and Luxemburg in a private placement.

dievini Hopp BioTech has committed up to EUR 80 million ($102.5 million) to exercise its subscription rights and to purchase new shares not subscribed or sold in the private placement to purchase in shares. Piper Jaffray and WestLB are joint global coordinators for the offering. ...